EBITDA for the quarter stood at ₹45 crore, down 47.4% from ₹85.4 crore reported in the identical quarter final 12 months. EBITDA margin got here in at 8.6% for the quarter, in contrast with 16% within the year-ago interval.
Additionally, the board has accepted the appointment of Dr Swati Patankar as a Non-Government Unbiased Director for a time period of 5 consecutive years with impact from February 5, 2026, topic to approval of the shareholders.
Additionally Learn: Unichem Labs’ Kolhapur API facility inspected by USFDA; 5 procedural observations
Dr Patankar will function an Unbiased Director from February 5, 2026, to February 4, 2031. She has greater than 35 years of expertise. She holds a B.Sc. (Hons) from St. Xavier’s Faculty, Mumbai, and a PhD in Molecular Microbiology from Tufts College, Boston, USA.
Dr Patankar is a Professor within the Division of Biosciences and Bioengineering at IIT Bombay. She has served as Dean (Worldwide Relations) and as a member of the Board of Governors at IIT Bombay, gaining administrative expertise throughout a number of domains.
Shares of Unichem Laboratories Ltd ended at ₹423.00, up by ₹5.35, or 1.28%, on the BSE.
Additionally Learn: Unichem Labs will get €19.5-million demand discover from European Fee in patent dispute case
First Printed: Feb 5, 2026 4:09 PM IST
Source link
#Unichem #Laboratories #Internet #Revenue #jumps #crore #income #EBITDA #CNBC #TV18
